Pediatric Cardiology Market is expected to reach US$ 10,389.77 Million by 2031

Transcatheter Heart Valves Segment to Lead Pediatric Cardiology Market Based on Product Type During 2024–2031

According to our new research study on “Pediatric Cardiology Market Forecast to 2031 – Global Analysis – by Product Type, Disease Indication, Surgical Procedure, and End User,” the market was valued at US$ 6,634.00 million in 2024 and is projected to reach US$ 10,389.77 million by 2031; it is expected to register a CAGR of 6.6% from 2024 to 2031. Major factors driving the market growth include the increasing incidence of congenital heart disease in pediatrics and the growing shift toward minimally invasive procedures.  

Pediatric cardiology is a specialized field of medicine that focuses on diagnosing, treating, and managing heart conditions in children, from infants to adolescents. This branch of cardiology addresses congenital heart defects (those present at birth), acquired heart conditions, and other cardiovascular issues that affect the pediatric population.

Pediatric Cardiology Market, by Region, 2024(%)

Source: The Insight Partners Analysis

Pediatric Cardiology Market Analysis Based on Segmental Evaluation:

Based on product type, the pediatric cardiology market is categorized into transcatheter heart valves, occlusion devices, catheters, stents, introducer sheaths, and others. In 2024, the transcatheter heart valves segment held a significant pediatric cardiology market share. Transcatheter heart valve is an alternative to open heart surgery for kids who have a failing, surgically placed heart valve. The transcatheter heart valve might not replace open-heart surgery as a treatment option, but it can help delay surgery and improve quality of life. Various pediatric hospitals are focusing on providing programs for opting for less invasive treatments; e.g., using transcatheter valves rather than open surgery to treat congenital heart defects. Children’s Hospital Los Angeles provides heart valve programs that support the use of new techniques and treatments to offer the best possible quality of life to children. The program offers excellent outcomes, world-renowned experts, and child-focused care. Similarly, the Heart Institute at Children's Hospital Colorado uses minimally invasive cardiac catheters to treat heart problems in kids. The institute’s Transcatheter Pulmonary Valve Program is a significant alternative to open-heart surgery that can improve life for children suffering from several types of congenital heart defects.

The scope of the pediatric cardiology market report includes an assessment of the market performance in North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In terms of revenue, North America dominated the pediatric cardiology market share in 2024. The increasing incidence of congenital heart disease, increasing strategic initiatives by companies, and government initiatives to improve cardiovascular disease prevention and treatment. Additionally, the rising prevalence of congenital anomalies and growing healthcare infrastructure are propelling the expansion of the pediatric cardiology market in the region.  

In North America, the US holds a significant share of the pediatric cardiology market. The US pediatric cardiology market’s growth trajectory is influenced by the increasing incidence of congenital heart disease (CHD) among children and a surging inclination toward minimally invasive procedures owing to its several advantages. As per the American Academy of Pediatrics, about 3–4% of infants in the US are born with congenital abnormalities, highlighting the need for specialized pediatric cardiologists and effective treatment techniques. Technologies such as fetal echocardiography, advanced imaging techniques, and minimally invasive surgeries have improved diagnosis and treatment procedures.

Additionally, increasing strategic initiatives such as product approvals, product launches, and collaborations are expected to create ample opportunities in the market in the coming years. In May 2024, Stanford Medicine researchers developed an implantable ventricular assistance device (VAD) that is surgically attached to the heart of children suffering from heart failure in order to enhance circulation and prevent the risk of heart failure while awaiting a donor’s heart for transplant.

With an increasing awareness of CHDs and advancements in medical technology, the pediatric cardiology market in Canada is experiencing steady growth. As per the BORN Ontario article published in February 2024, CHD affects 12.3 out of every 1,000 births, which means about 4,400 neonates are born with CHDs annually in the country, making pediatric cardiology essential to ensure early diagnosis and timely treatment.

The Canadian government provides financial support for pediatric cardiology services and medical technologies through provincial health plans and national health agencies, making healthcare largely accessible to all children. The government supports initiatives to improve cardiovascular disease prevention, diagnosis, and treatment through awareness campaigns and partnerships with healthcare institutions. The Canadian Pediatric Cardiology Association established the Canadian Pediatric Cardiology Research Network (CPCRN) to connect Canadian academic institutions, fostering collaboration and advancing pediatric and congenital cardiology research. CPCRN provides a comprehensive structure that assists Canadian pediatric and congenital cardiology researchers in planning, designing, and coordinating effective studies, ultimately enabling the execution of impactful and significant research projects across Canada. Innovative technologies are playing a key role in expanding the capabilities of pediatric cardiology. In June 2024, Cook Medical introduced its Beacon Tip sizing catheters in the US and Canada. These catheters come in various lengths and tip configurations, designed to accommodate various patient anatomies and conditions. Particularly beneficial in pediatric cardiology, the Beacon Tip sizing catheters enable more precise and individualized catheterization, helping physicians optimize treatment for children with complex heart conditions.

Abbott Laboratories, Medtronic Plc, Edwards Lifesciences Corp, Terumo Corp, W L Gore and Associates Inc, NuMED, Cordis Corp, Occlutech US LLC, Biotronik SE & Co KG, and RENATA MEDICAL are among the leading companies profiled in the pediatric cardiology market report.

Based on product type, the pediatric cardiology market is segmented into transcatheter heart valves, occlusion devices, catheters, stents, introducer sheaths, and others. By disease indication, the pediatric cardiology market is segmented into congenital heart disease, acquired heart disease, arrhythmias, cardiomyopathies, and others. By surgical procedure, the pediatric cardiology market is segmented into interventional procedures, heart rhythm management procedures, and others. In terms of end user, the pediatric cardiology market is segmented into hospitals, specialty clinics, and others. Geographically, the market is categorized into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com